Fycompa (Perampanel Oral Suspension) and Insulin glargine and lixisenatide
Determining the interaction of Fycompa (Perampanel Oral Suspension) and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: perampanel
Brand name: Fycompa
Synonyms: Fycompa
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fycompa (Perampanel Oral Suspension)-Insulin glargine and lixisenatide Subcutaneous
- Fycompa (Perampanel Oral Suspension)-Insulin glargine, recombinant Subcutaneous
- Fycompa (Perampanel Oral Suspension)-Insulin glulisine
- Fycompa (Perampanel Oral Suspension)-Insulin Glulisine (Cartridges and Pens)
- Fycompa (Perampanel Oral Suspension)-Insulin Glulisine (Vials)
- Fycompa (Perampanel Oral Suspension)-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Fycompa (Perampanel Tablets)